| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Development Officer
1 company
Bozigian Haig P. is a Chief Development Officer at NEUROCRINE BIOSCIENCES INC. Recent SEC Form 4 filings include 0 buys and 16 sells.
Estimated insider holdings value: $25.9M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Jun 18, 2019 | NBIX Neurocrine Biosciences Inc | Chief Development Officer | Sale+OE | 2,100 | $87.82 | $184,416.54 | -1.5% | |
| Jun 13, 2019 | NBIX Neurocrine Biosciences Inc | Chief Development Officer | Sale+OE | 17,268 | $82.62 | $1,426,627.81 | -5.7% | |
| Jun 3, 2019 | NBIX Neurocrine Biosciences Inc | Chief Development Officer | Sale+OE | 3,435 | $85.51 | $293,718.61 | -2.4% | |
| May 31, 2019 | NBIX Neurocrine Biosciences Inc | Chief Development Officer | Sale+OE | 19,297 | $85.02 | $1,640,580.77 | -12.0% | |
| May 24, 2019 | NBIX Neurocrine Biosciences Inc | Chief Development Officer | Sale+OE | 17,486 | $80.03 | $1,399,434.31 | -11.0% | |
| May 22, 2019 | NBIX Neurocrine Biosciences Inc | Chief Development Officer | Sale+OE | 1,300 | $80.03 | $104,037.05 | -0.9% | |
| May 16, 2019 | NBIX Neurocrine Biosciences Inc | Chief Development Officer | Sale+OE | 66,667 | $80.13 | $5,341,893.38 | -10.5% | |
| May 13, 2019 | NBIX Neurocrine Biosciences Inc | Chief Development Officer | Sale+OE | 34,547 | $75.51 | $2,608,813.25 | -19.6% | |
| Feb 6, 2019 | NBIX Neurocrine Biosciences Inc | Chief Development Officer | Sell | 920 | $83.54 | $76,859.38 | -0.6% | |
| Feb 5, 2019 | NBIX Neurocrine Biosciences Inc | Chief Development Officer | Sell | 2,725 | $88.12 | $240,125.44 | -0.7% |